Skip to main content
Top
Published in: Digestive Diseases and Sciences 11/2010

01-11-2010 | Editorial

Predictive Algorithms: Uses and Limitations

Authors: Janice H. Jou, Deborah A. Fisher

Published in: Digestive Diseases and Sciences | Issue 11/2010

Login to get access

Excerpt

Hepatocellular carcinoma (HCC) has emerged as an area in urgent need of epidemiologic and outcomes research due to the continuing rise in incidence and mortality over time [1]. The overall 5-year survival from 2003 to 2007 was 14% in the Surveillance, Epidemiology, and End Results (SEER) Program database of the National Cancer Institute [2]. Although this survival rate may be disheartening, subsets of patients with limited tumor burden at diagnosis are candidates for curative therapies including liver transplantation, resection, or tumor ablation. These patients have significantly improved survival; specifically, patients receiving liver transplantation for early-stage disease have 5-year survival of over 70% [3]. …
Literature
1.
go back to reference Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116:544–573.CrossRefPubMed Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116:544–573.CrossRefPubMed
3.
go back to reference Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693–699.CrossRefPubMed Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693–699.CrossRefPubMed
4.
go back to reference Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology, July 2010. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology, July 2010.
5.
go back to reference Bruix, J, Sherman, M, Llovet, JM et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European association for the study of the liver. J Hepatol. 2001;35:421–430. Bruix, J, Sherman, M, Llovet, JM et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European association for the study of the liver. J Hepatol. 2001;35:421–430.
6.
go back to reference Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol. 2004;130:417–422.PubMed Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol. 2004;130:417–422.PubMed
7.
go back to reference Richardson P, Henderson L, Davila JA, Kramer JR, Fitton CP, Chen GJ, El-Serag HB. Surveillance for hepatocellular carcinoma: development and validation of an algorithm to classify tests in administrative and laboratory data. Dig Dis Sci. 2010. doi:10.1007/s10620-010-1387-y. Richardson P, Henderson L, Davila JA, Kramer JR, Fitton CP, Chen GJ, El-Serag HB. Surveillance for hepatocellular carcinoma: development and validation of an algorithm to classify tests in administrative and laboratory data. Dig Dis Sci. 2010. doi:10.​1007/​s10620-010-1387-y.
Metadata
Title
Predictive Algorithms: Uses and Limitations
Authors
Janice H. Jou
Deborah A. Fisher
Publication date
01-11-2010
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 11/2010
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-010-1436-6

Other articles of this Issue 11/2010

Digestive Diseases and Sciences 11/2010 Go to the issue